Markets
Charts & Ideas
Algo
News
Store
Brokers
Download

Economic Calendar
Trading Signals
WebTerminal
Heatmap

Type / to search: @user, $symbol Search

Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe

PPCB

#4922

Propanc Biopharma, Inc. - Common Stock

0.4 1 USD

-0.07%

Market Price

Sector: Healthcare

Base: USD

Profit Currency: USD

Daily Range

0.41

0.44

Year Range

0.06

6.79

Daily Change

-6.82%

Monthly Change

-52.33%

6 month change

+320.51%

Year Change

-76.84%

Previous Close

0.4 4

Open

0.4 3

Low

0.4 1

High

0.4 4

Markets
US Stock Market
Healthcare
Drug Manufacturers—General
PPCB

Open full chart

Financials

Overview Statement Statistics Documents

Income statement Balance sheet Cash flow

Value 202020212022202320242025 TTM Total revenue 0000-960.28 K0 48.47 K Gross profit 0000-960.28 K0 48.47 K Operating expenses 1.81 M1.99 M1.78 M1.54 M57.28 M18.19 M 18.19 M Selling/general/admin expenses 1.55 M1.71 M1.5 M1.25 M57.03 M670.61 K 670.61 K Research & development 230.96 K256.05 K247.92 K248.1 K223.72 K625.48 K 625.48 K Operating income -1.81 M-1.99 M-1.78 M-1.54 M-57.28 M-18.19 M -18.19 M Non-Operating Income, Total -327.22 K-722.19 K-1.01 M-413.61 K-1.65 M-677.14 K -677.14 K Interest expense, net of interest capitalized 449.46 K568.8 K532.82 K665.84 K563.76 K430.54 K 430.54 K Non-Operating Income, excl. Interest Expenses -776.68 K-1.29 M-1.55 M-413.61 K-1.65 M-671.14 K -725.14 K Unusual income/expense —————-6 000 -6 000 Pretax income -2.14 M-2.71 M-2.79 M-1.95 M-58.92 M-18.86 M -18.86 M Equity in earnings —————— — Taxes -113.41 K-54.98 K-129.84 K-129.13 K00 — Non-controlling/minority interest —————— — After tax other income/expense -16.5 K-2 250-1 838-3 832-5 519-6 781 -6 781 Net income before discontinued operations -2.42 M-2.66 M-2.66 M-1.82 M-58.92 M-18.86 M -18.86 M Discontinued operations —————— — Net income -2.42 M-2.66 M-2.66 M-1.82 M-58.92 M-18.86 M -18.86 M Dilution adjustment —00000 0 Preferred dividends —700.34 K466.27 K192.96 K0932.25 K 932.25 K Diluted net income available to common stockholders -2.42 M-3.36 M-3.13 M-2.01 M-58.92 M-19.79 M -19.79 M Basic earnings per share (Basic EPS) —-75 M-2.7 M-30 K-371.25-17.62 -17.62 Diluted earnings per share (Diluted EPS) —-58.45 M-2.7 M-30 K-371.25-17.62 -17.62 Average basic shares outstanding —0.051.1656.7158.73 K1.12 M — Diluted shares outstanding —0.051.1656.7158.73 K1.12 M — EBITDA -1.59 M-1.46 M-1.46 M-1.15 M-58.19 M-18.13 M -18.08 M EBIT -1.81 M-1.99 M-1.78 M-1.54 M-58.24 M-18.19 M -18.14 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 218.4 K527.8 K313.45 K383.91 K46.2 K58.3 K 58.3 K

Markets

US Stock Market
Currencies
Cryptocurrencies
Metals
Commodities

Charts & Ideas

Trading Ideas
Education Ideas
Charts

MQL5 Community

Store
Signals
Forum
Articles
CodeBase

News

US Stock Market
Currencies
Cryptocurrencies
Metals
Commodities

Brokers

All Brokers
Forex
Stocks
Metals

Economic Calendar

Subscribe to algo trading news

Risk Disclosure Terms of Use Help Contacts and Requests Legal

Copyright 2000-2026, MetaQuotes Ltd